Scinai Immunotherapeutics (SCNI) Exchange Rate Effect (2018 - 2026)
Scinai Immunotherapeutics (SCNI) reported Exchange Rate Effect of $3.1 million for Q1 2026, up 171.02% on a YoY basis from $1.1 million in Q1 2025, and up 381.3% sequentially from -$1.1 million in Q2 2025.
Scinai Immunotherapeutics (SCNI) Exchange Rate Effect (2018 - 2026) Analysis & Trends
Scinai Immunotherapeutics (SCNI) has 9 years of Exchange Rate Effect data on file, last reported at $3.1 million in Q1 2026.
- For the quarter ending Q1 2026, Exchange Rate Effect rose 171.02% year-over-year to $3.1 million; the trailing twelve-month figure through Mar 2026 stood at $3.2 million (up 182.54% YoY), and the FY2025 full-year result was $1000.0, up 111.11% from the prior year.
- Exchange Rate Effect climbed to $3.1 million in Q1 2026, from -$1.1 million in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $5.0 million in Q1 2024 to a low of -$4.8 million in Q2 2024.
- A 5-year average of $196600.0 and a median of -$41000.0 in 2023 frame the typical range for Exchange Rate Effect.
- Peak annual rise in Exchange Rate Effect reached 2316.96% in 2024, while the deepest fall reached 11717.07% in 2024.
- Tracing SCNI's Exchange Rate Effect over 5 years: stood at -$151000.0 in 2022, then surged by 90.73% to -$14000.0 in 2023, then surged by 114.29% to $2000.0 in 2024, then plunged by 55450.0% to -$1.1 million in 2025, then surged by 381.3% to $3.1 million in 2026.
- Business Quant data shows SCNI's Exchange Rate Effect at $3.1 million in Q1 2026, -$1.1 million in Q2 2025, and $1.1 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 19.32 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 14,631.83 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Scinai Immunotherapeutics | 352,860.00 | -3.11 Bn | -1.12 Mn | 3.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.11 Mn |
| Mar 31, 2026 | 3.11 Mn |
| Jun 30, 2025 | -1.11 Mn |
| Jun 30, 2025 | -1.11 Mn |
| Mar 31, 2025 | 1.15 Mn |
| Mar 31, 2025 | 1.15 Mn |
| Dec 31, 2024 | 2,000.00 |
| Dec 31, 2024 | 2,000.00 |
| Sep 30, 2024 | -132,000.00 |
| Sep 30, 2024 | -132,000.00 |
| Jun 30, 2024 | -4.85 Mn |
| Jun 30, 2024 | -4.85 Mn |
| Mar 31, 2024 | 4.97 Mn |
| Mar 31, 2024 | 4.97 Mn |
| Dec 31, 2023 | -14,000.00 |
| Dec 31, 2023 | -14,000.00 |
| Sep 30, 2023 | 7,000.00 |
| Sep 30, 2023 | 7,000.00 |
| Jun 30, 2023 | -41,000.00 |
| Jun 30, 2023 | -41,000.00 |